These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1310463)

  • 21. [Transforming Growth Factor Beta: structure, biologic effects and mechanism of action].
    Benzakour O
    Bull Cancer; 1994 Dec; 81(12):1014-22. PubMed ID: 7742590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice.
    Kinbara T; Shirasaki F; Kawara S; Inagaki Y; de Crombrugghe B; Takehara K
    J Cell Physiol; 2002 Mar; 190(3):375-81. PubMed ID: 11857453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts.
    Tischler M
    N Y State Dent J; 2002 Mar; 68(3):22-4. PubMed ID: 11989332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing.
    Beck LS; DeGuzman L; Lee WP; Xu Y; Siegel MW; Amento EP
    J Clin Invest; 1993 Dec; 92(6):2841-9. PubMed ID: 8254038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix.
    Tseng SC; Li DQ; Ma X
    J Cell Physiol; 1999 Jun; 179(3):325-35. PubMed ID: 10228951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
    Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
    Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-beta: a key mediator of fibrosis.
    Mauviel A
    Methods Mol Med; 2005; 117():69-80. PubMed ID: 16118446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
    Ito M; Yasui W; Kyo E; Yokozaki H; Nakayama H; Ito H; Tahara E
    Cancer Res; 1992 Jan; 52(2):295-300. PubMed ID: 1309437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.
    Ashcroft GS; Yang X; Glick AB; Weinstein M; Letterio JL; Mizel DE; Anzano M; Greenwell-Wild T; Wahl SM; Deng C; Roberts AB
    Nat Cell Biol; 1999 Sep; 1(5):260-6. PubMed ID: 10559937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transforming growth factor-beta system and the kidney.
    Sharma K; Ziyadeh FN
    Semin Nephrol; 1993 Jan; 13(1):116-28. PubMed ID: 8381979
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling].
    Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding and internalization of transforming growth factor-beta 1 by human hepatoma cells: evidence for receptor recycling.
    Sathre KA; Tsang ML; Weatherbee JA; Steer CJ
    Hepatology; 1991 Aug; 14(2):287-95. PubMed ID: 1650327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta: the breaking open of a black box.
    Alevizopoulos A; Mermod N
    Bioessays; 1997 Jul; 19(7):581-91. PubMed ID: 9230691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transforming growth factor-beta family.
    Massagué J
    Annu Rev Cell Biol; 1990; 6():597-641. PubMed ID: 2177343
    [No Abstract]   [Full Text] [Related]  

  • 37. Transforming growth factor-beta1: its anti-inflammatory and pro-fibrotic effects.
    Ling E; Robinson DS
    Clin Exp Allergy; 2002 Feb; 32(2):175-8. PubMed ID: 11929477
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of transforming growth factor beta in colorectal cancer.
    Lahm H; Odartchenko N
    Growth Factors; 1993; 9(1):1-9. PubMed ID: 8394093
    [No Abstract]   [Full Text] [Related]  

  • 39. Transforming growth factor-beta: recent progress and new challenges.
    Sporn MB; Roberts AB
    J Cell Biol; 1992 Dec; 119(5):1017-21. PubMed ID: 1332976
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of transforming growth factor-beta in repair and fibrosis.
    Raghow R
    Chest; 1991 Mar; 99(3 Suppl):61S-65S. PubMed ID: 1997279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.